Walleye Trading’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-136
Closed -$3.29K 4376
2025
Q3
$3.29K Buy
+136
New +$2.27K ﹤0.01% 4263
2025
Q1
Sell
-850
Closed -$24.3K 4111
2024
Q4
$31.5K Buy
+850
New +$32.5K ﹤0.01% 3877
2024
Q3
Sell
-109
Closed -$6.05K 4146
2024
Q2
$8.98K Sell
109
-1,810
-94% -$196K ﹤0.01% 3890
2024
Q1
$278K Buy
1,919
+1,823
+1,899% +$154K ﹤0.01% 3238
2023
Q4
$8.86K Sell
96
-648
-87% -$65.9K ﹤0.01% 4631
2023
Q3
$123K Buy
+744
New +$96.7K ﹤0.01% 3871
2022
Q4
Sell
-44
Closed -$2.72K 4996
2022
Q3
$4K Sell
44
-1,292
-97% -$184K ﹤0.01% 4670
2022
Q2
$298K Buy
1,336
+1,120
+519% +$375K ﹤0.01% 3386
2022
Q1
$119K Buy
+216
New +$131K ﹤0.01% 4142
2021
Q1
Sell
-148
Closed -$211K 4837
2020
Q4
$211K Buy
+148
New +$158K ﹤0.01% 3463
2020
Q1
Sell
-371
Closed -$233K 4020
2019
Q4
$233K Buy
+371
New +$181K ﹤0.01% 3045

Other funds holding CDLX

Walleye Trading's CDLX Position: Q4 2025 in Review

Walleye Trading sold out of Cardlytics (CDLX) in Q4 2025, closing a stake of 136 shares — an estimated $3.29K sold.

Walleye Trading first reported a position in CDLX in Q4 2019 and held it in 11 quarters. The position peaked at $298K in Q2 2022. 70 funds tracked by Wall St. Rank hold CDLX as of Q4 2025.

  • Walleye Trading reported no remaining Cardlytics position as of Q4 2025 after selling out during the quarter.
  • Walleye Trading sold 136 Cardlytics shares in Q4 2025, an estimated $3.29K.
  • Walleye Trading first reported a position in Cardlytics in Q4 2019 and held it in 11 quarters.
  • Walleye Trading's Cardlytics position peaked at $298K in Q2 2022.
  • 70 funds tracked by Wall St. Rank held Cardlytics as of Q4 2025.

Based on Walleye Trading's 13F filing for Q4 2025, filed 13 Feb 2026.